Following on from World Antibiotic Awareness Week (WAAW), which took place from 18 to 22 November, there has been considerable discussion surrounding how to prevent the further emergence and spread of antimicrobial resistance. This year's campaign marks the first in a new five-year National Action Plan in the UK for tackling antimicrobial resistance, which will aim to reduce inappropriate prescribing and control and prevent infection (NHS England, 2019).
Developing resistance
The development of antibiotics has been revolutionary for medicine and public health. However, given the resistance that is now building up against them, we are facing one of the most significant and urgent threats to global health. As former Prime Minister David Cameron put it: ‘If we fail to act, we are looking at an almost unthinkable scenario where antibiotics no longer work and we are cast back into the dark ages of medicine.’ (Review on Antimicrobial Resistance, 2016)
Antimicrobial stewardship
Many nurses in the community may increasingly find themselves in the role of non-medical prescriber. Prescribers can contribute to preventing the spread of antibiotic resistance in various ways. The Centers for Disease Control and Prevention (CDC) (2017a) in the United States recommends the following:
Empowering patients
In this age of the informed and empowered patient, health professionals are no longer in the paternalistic position of treating patients without their involvement. The problem of antimicrobial resistance belongs to every member of society (Ashiru-Oredope, 2019); however, many patients probably are unaware of how they might take any action against this global threat.
The CDC (2017b) provides the following advice for the general public, which can aid health professionals in supporting and educating patients:
Progress report
In 2014, a review was commissioned by the then UK Prime Minister to analyse the global issue of rising drug resistance and drug-resistant infections, and to propose concrete actionable steps that could be taken in an effort to tackle the problem internationally (Review on Antimicrobial Resistance, 2016). However, a recently published progress report noted that, while there has been progress in raising awareness, there is less evidence about any impact being made on behaviour (The Pharmaceutical Journal, 2019). In fact, it is suggested that ‘multinational pharmaceutical companies actually have fewer projects to develop antibiotics than they did when the report was launched 3 years ago’ (The Pharmaceutical Journal, 2019).
Conclusion
It was estimated by the World Health Organization (WHO) that half of all antibiotic prescriptions in 2015 were for viral conditions, for which they do not provide any benefits (Sprenger, 2015). While drugs will inevitably lose their ability to kill the bacteria that cause diseases over time as a result of the natural selection and genetic adaptation of bacteria, there is much that can be done to slow this process, such as more generous and rapid investment in new drug development; more effective use of infection prevention strategies; safe, informed and sparing use of antibiotics by patients; and a push towards appropriate prescribing in what has become an over-medicalised society.